General Information of This Linker
Linker ID
LIN0GKUTR
Linker Name
(Linker-02)MC-PEG-VA-PAB
Linker Type
Cathepsin-cleavable linker
Antibody-Linker Relation
Cleavable
Structure
Formula
C41H65N5O15
Isosmiles
CC([C@@H](NC(CCOCCOCCOCCOCCOCCOCCOCCOCCNC(CCN1C(C=CC1=O)=O)=O)=O)C(N[C@@H](C)C(NC2=CC=C(C=C2)CO)=O)=O)C
InChI
InChI=1S/C41H65N5O15/c1-31(2)39(41(53)43-32(3)40(52)44-34-6-4-33(30-47)5-7-34)45-36(49)11-14-54-16-18-56-20-22-58-24-26-60-28-29-61-27-25-59-23-21-57-19-17-55-15-12-42-35(48)10-13-46-37(50)8-9-38(46)51/h4-9,31-32,39,47H,10-30H2,1-3H3,(H,42,48)(H,43,53)(H,44,52)(H,45,49)/t32-,39+/m0/s1
InChIKey
YJYDWLGCCNOUSJ-NXVGIJDASA-N
Pharmaceutical Properties
Molecule Weight
867.991
Polar area
247.85
Complexity
1373.587817
xlogp Value
-0.2829
Heavy Count
61
Rot Bonds
37
Hbond acc
15
Hbond Donor
5
Each Antibody-drug Conjugate Related to This Linker
Full Information of The Activity Data of The ADC(s) Related to This Linker
wO2024169913A1 ADC01-08-8 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.0089 nM
High HER2 expression (HER2+++)
Method Description
Cytotoxicity of ADC to SK-BR-3 cells
In Vitro Model Breast adenocarcinoma SK-BR-3 cells CVCL_0033
wO2024169913A1 ADC04-08-8 [Investigative]
Revealed Based on the Cell Line Data
Click To Hide/Show 1 Activity Data Related to This Level
Experiment 1 Reporting the Activity Date of This ADC [1]
Efficacy Data Half Maximal inhibitory Concentration (lC50)
0.118 nM
High DLL3 expression (DLL3+++)
Method Description
Cytotoxicity of ADC to NCI-H82 cells
In Vitro Model Lung small cell carcinoma NCI-H82 cells CVCL_1591
References
Ref 1 Domide molecular glue derivative and use thereof